0001209191-22-034068.txt : 20220603
0001209191-22-034068.hdr.sgml : 20220603
20220603163335
ACCESSION NUMBER: 0001209191-22-034068
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220601
FILED AS OF DATE: 20220603
DATE AS OF CHANGE: 20220603
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Crean David Hugh
CENTRAL INDEX KEY: 0001810100
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36003
FILM NUMBER: 22995054
MAIL ADDRESS:
STREET 1: C/O HISTOGEN INC.
STREET 2: 10655 SORRENTO VALLEY ROAD, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Histogen Inc.
CENTRAL INDEX KEY: 0001383701
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 203183915
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10655 SORRENTO VALLEY ROAD
STREET 2: SUITE 200
CITY: San Diego
STATE: CA
ZIP: 92121
BUSINESS PHONE: (858) 526-3100
MAIL ADDRESS:
STREET 1: 10655 SORRENTO VALLEY ROAD
STREET 2: SUITE 200
CITY: San Diego
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: Conatus Pharmaceuticals Inc.
DATE OF NAME CHANGE: 20140729
FORMER COMPANY:
FORMER CONFORMED NAME: Conatus Pharmaceuticals Inc
DATE OF NAME CHANGE: 20061214
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-06-01
0
0001383701
Histogen Inc.
HSTO
0001810100
Crean David Hugh
C/O HISTOGEN INC.
10655 SORRENTO VALLEY ROAD, SUITE 200
SAN DIEGO
CA
92121
1
0
0
0
Stock Option (right to buy)
3.20
2022-06-01
4
A
0
1000
0.00
A
2032-06-01
Common Stock
1000
1000
D
On June 2, 2022, the Issuer effected a 1-for-20 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 and the exercise price have been adjusted to reflect the Reverse Stock Split.
This option was issued to the Reporting Person, a non-employee director of the Issuer, for his service as a director of the Issuer.
The shares subject to this option become fully vested and exercisable on 6/1/2023, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.
/s/ Susan A. Knudson as attorney-in-fact for David Hugh Crean
2022-06-03